| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/21/1999 | EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/21/1999 | CN1214686A Derivatives of camptothecin for use in treating cancer |
| 04/21/1999 | CN1214685A Inhibitors of farnesyl protein transferase |
| 04/21/1999 | CN1214681A New phenanthridines |
| 04/21/1999 | CN1214244A Use of rifaximin and of pharmaceutical compositions containing it in treatment of diarrhoea from cryptosporidiosis |
| 04/15/1999 | WO1999018085A2 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 04/15/1999 | WO1999018077A1 Fused pyridine derivatives |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999005103A3 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent |
| 04/15/1999 | DE19744257A1 New tetracyclic pyrido-indole derivatives |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2304513A1 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 04/14/1999 | EP0907642A1 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
| 04/14/1999 | EP0907641A1 Fluoroionophores and their use in optical ion sensors |
| 04/14/1999 | EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| 04/13/1999 | CA2155236C Gas phase polymerization process |
| 04/08/1999 | WO1999016752A1 β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING |
| 04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue |
| 04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
| 04/07/1999 | EP0906317A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906316A1 Novel water-soluble analogues of 20(s)-camptothecin |
| 04/07/1999 | EP0906315A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 04/07/1999 | EP0906314A1 Optical resolution of narwedine-type compounds |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906284A1 Tricyclic amine derivatives |
| 04/07/1999 | EP0607374B1 Novel cyclic lipid derivatives as potent paf antagonists |
| 04/07/1999 | CN1213373A Pyrimidin-4-one-derivatives as pesticide |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/06/1999 | US5892037 Polymeric adducts of hindered amine-epoxides as stabilizers |
| 04/06/1999 | US5891882 Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891871 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 04/01/1999 | WO1999015517A1 Sulfonated xanthene derivatives |
| 04/01/1999 | WO1999015516A1 Novel neuropeptide y receptor antagonists |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2272403A1 Sulfonated xanthene derivatives |
| 03/31/1999 | EP0796298B1 Benzopyran dyes and their intermediates |
| 03/31/1999 | EP0714395B1 Vasoconstrictive substituted dihydropyranopyridines |
| 03/31/1999 | CN1212691A Tricyclic compound and its preparation and use |
| 03/30/1999 | US5889044 Trans-6-acetyl-4s-(4-fluorobenzoylamino)-3,4,-dihydro-2,2-dimethyl -2h-1-benzopyran and pharmaceutical salts |
| 03/30/1999 | US5889018 Heterocyclic compounds, pharmaceutical compositions comprising them and process for the preparation thereof |
| 03/30/1999 | US5889001 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 03/30/1999 | US5888992 Polar substituted hydrocarbons |
| 03/25/1999 | WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues |
| 03/25/1999 | WO1999014196A1 Method for the synthesis of quinoline derivatives |
| 03/25/1999 | CA2303299A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues |
| 03/25/1999 | CA2303026A1 Method for the synthesis of quinoline derivatives |
| 03/24/1999 | CN1211987A Camptothecin derivatives and use thereof as antimutor agents |
| 03/24/1999 | CN1211986A Pyridonecarboxylic acid derivatives and intermediates for synthesis thereof |
| 03/24/1999 | CN1211985A Fused imidazole derivatives as multidrug resistance modulators |
| 03/24/1999 | CN1211575A Novel compound |
| 03/23/1999 | US5886192 L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds |
| 03/23/1999 | US5886180 25-methylene and 24-25 -epoxy marcfortines and paraherquamides |
| 03/23/1999 | US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents |
| 03/23/1999 | US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors |
| 03/23/1999 | US5886016 Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| 03/23/1999 | US5886002 Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis |
| 03/23/1999 | US5886001 Agonist compounds |
| 03/23/1999 | US5885999 Treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 03/18/1999 | WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors |
| 03/18/1999 | WO1999012929A2 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom |
| 03/17/1999 | EP0901492A1 Taxane derivatives, the preparation thereof and formulations containing them |
| 03/17/1999 | EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones |
| 03/17/1999 | CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon |
| 03/17/1999 | CN1211252A Coralyne analogs as topoisomerase inhibitors |
| 03/16/1999 | US5883252 Aspartyl protease inhibitors |
| 03/16/1999 | CA2131545C Substituted pyrimidines and their use as pesticides |
| 03/16/1999 | CA2081891C Quinolizinone type compounds |
| 03/11/1999 | WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/11/1999 | WO1999011646A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same |
| 03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | WO1999011627A1 2-substituted phenyl-benzimidazole antibacterial agents |
| 03/11/1999 | WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 03/11/1999 | WO1999011623A1 Thioalkyl compounds, methods, and compositions for inhibiting parp activity |
| 03/11/1999 | WO1999011619A1 Phenylindole derivatives as 5-ht2a receptor ligands |
| 03/11/1999 | WO1999011258A1 Lymphocyte function antigen-1 antagonists |
| 03/11/1999 | DE19738578A1 Carboxylic acid derivatives useful as endothelin A and B antagonists also active as renin and angiotensin inhibitors |
| 03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 03/11/1999 | CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/10/1999 | EP0900798A1 Fulgimide compounds, use of them, and compositions containing the same |
| 03/10/1999 | EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
| 03/10/1999 | EP0900023A1 Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators |
| 03/10/1999 | CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 03/09/1999 | US5880131 Polyoxyalkylene derivatives |
| 03/09/1999 | US5880126 9H-Pyridu ((3,4-b) indole derivatives |
| 03/09/1999 | US5879837 Styrylcoumarin compound, photosensitive resin composition, and hologram recording medium |
| 03/04/1999 | WO1999010351A1 Pyridonecarboxylic acid derivatives and intermediates for the preparation thereof |
| 03/04/1999 | WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 03/04/1999 | WO1999009996A1 Camptothecin analogs and methods of preparation thereof |
| 03/04/1999 | WO1999009987A1 Method for treating premenstrual or late luteal phase syndrome |
| 03/04/1999 | WO1999009845A1 Imidazoquinoxaline protein tyrosine kinase inhibitors |
| 03/04/1999 | WO1998055454A3 Benzofurans and benzothophenes as suppressors of neurodegeneration |
| 03/04/1999 | WO1998019648A3 N-oxy-naphthalimides as antibacterial agents |
| 03/04/1999 | CA2298979A1 Method for treating premenstrual or late luteal phase syndrome |
| 03/03/1999 | EP0898571A1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin |